Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Reference Laboratories, Inc. Reaffirms Guidance, Sees Continued Strong Growth and Increasing Demand for Laboratory Services.


Business Editors

ELMWOOD PARK Elmwood Park, village (1990 pop. 23,206), Cook co., NE Ill., a suburb of Chicago; inc. 1914. It is chiefly residential. , N.J.--(BUSINESS WIRE)--Oct. 7, 2002

Bio-Reference Laboratories, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: BRLI BRLI Bio Rad Laboratories Inc ) announced today that it reaffirms its guidance that was previously upgraded earlier this year.

The Company continues to expect a twenty (20%) increase in revenues and at least a one hundred (100%) percent increase in pre-tax net income for the current fiscal year.

Marc D. Grodman M.D., President and Chief Executive Officer commented, "In light of recent announcements by other publicly traded clinical laboratories, Bio-Reference feels that it is important to re-assure the markets that Bio-Reference has continued to see growth in all aspects of its business and that demand for its laboratory testing has not abated Abated, an ancient technical term applied in masonry and metal work to those portions which are sunk beneath the surface, as in inscriptions where the ground is sunk round the letters so as to leave the letters or ornament in relief.

From 1911 Encyclopædia Britannica
. We believe that market forces are favoring regional and specialty niche laboratories like Bio-Reference to fully benefit from this growth. Routine testing has continued to grow as expected and the Company's focused marketing efforts in specialty markets has expanded significantly. New technologies and advancements in technology are expanding the menu of laboratory testing to monitor and diagnose disease states. These emerging technologies are providing constant opportunities for the Company to execute its strategy and continue strong double-digit growth into the foreseeable future."

About Bio-Reference Laboratories, Inc.

The Company is the largest independent regional clinical laboratory in the Northeast and has major market positions in physician offices, nursing homes and correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health, and complimentary medicine. PSIMedica, a business unit of the Company, is a clinical knowledge management (CKM CKM Cabibbo-Kobayashi-Maskawa (quark mixing matrix)
CKM Certified Knowledge Manager (trademark of Hudson Associates Consulting, Inc.
) organization offering an array of information solutions for reducing healthcare costs and improving quality performance that are based on a flexible, scalable software analytical engine A programmable calculator designed by British scientist Charles Babbage. After his Difference Engine failed its test in 1833, Babbage started the design of the Analytical Engine in 1834.  that utilizes all available source information, including claims data, enrollment data, prescription data and laboratory data. The Company provides a comprehensive connectivity solution to physicians that includes disease management, laboratory reporting and ordering, as well as claims eligibility and processing through CareEvolve, its web-based healthcare portal.

Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
". Statements looking forward in time are included in this release pursuant to the "safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to be materially different from any future performance suggested herein.

www.bioreference.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 7, 2002
Words:411
Previous Article:Fannie Mae Redemption.
Next Article:Virtual, Inc. Earns Association Management Company Accreditation From the ASAE; Association Management Company One of Only 44 Certified Companies...
Topics:



Related Articles
Bio-Reference Laboratories, Inc. Holds Year-end Analysts' Conference Call; Bio-Reference Joined On Call by CEO of Roche Diagnostics.
Bio-Reference Laboratories Continues Record Net Income On Record Revenues.
Bio-Reference Laboratories, Inc. Adjusts Guidance and Announces 2002 Year End Earnings Date; Company On Track with Upgraded Guidance For Fiscal 2002.
Bio-Reference Laboratories, Inc. Confirms Street Estimates on Conference Call.
Bio-Reference Laboratories, Inc. Affirms Guidance; Announces Stock Buy-Back Plan in Earnings Announcement.
Bio-Reference Laboratories, Inc. Reports Record Revenues, Record Net Income Despite Adverse Conditions.
Bio-Reference Laboratories, Inc. Announces Substantial Gains on Record Operating Results, Including a 53% Increase in Taxed Net Income on a 16%...
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 19% Increase for Q2 and 23% Increase in Net...
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 18% Increase in Net Revenues and 93% Increase in...
Bio-Reference Laboratories, Inc. Announces Agreement to Acquire Gene-Based Testing Laboratory, Third Quarter Results and Reaffirms Guidance for Year;...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles